Skip to main content
Premium Trial:

Request an Annual Quote

ABI and Solexa's Sequencing Strategies Top Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 22.
1. ABI and Solexa, Pitching Wall Street, Flesh Out Strategies for Their Sequencers (from Sept. 18)
2. Sigma-Aldrich Settles IP-Infringement Suit With Enzo (from Sept. 19)
3. Gene Logic Says Review Confirms That Genomics Unit Is Weak, Drug Repositioning Has Legs (from Sept. 22)
4. Epigenomics Licenses Health Discovery's SVM Technology for DNA Methylation Analysis (from Sept. 19)
5. Investment Bank Cuts Illumina Shares Though Says Genotyping Tech 'Best in Class' (from Sept. 18)
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.